Compounds, pharmaceutical compositions, and methods for inhibiting cyclin-dependent kinases
申请人:——
公开号:US20030220326A1
公开(公告)日:2003-11-27
Pharmaceutical compositions containing effective amounts of CDK-inhibiting diaminothiazole compounds of the following formula (where R
1
and R
2
are as defined in the specification) or their salts, or prodrugs or active metabolites of such compounds or salts, are useful for treating disorders and diseases such as cancer:
1
In preferred embodiments, R
1
and R
2
are independently unsubstituted or substituted carbocyclic or heterocyclic aryl ring structures. Compounds where R
2
is ortho-substituted aryl are especially potent inhibitors of CDKs such as CDK4.